Multiple myeloma can be accurately diagnosed in acute kidney injury patients using a rapid serum free light chain test
Open Access
- 20 July 2017
- journal article
- research article
- Published by Springer Nature in BMC Nephrology
- Vol. 18 (1) , 247
Abstract
Acute kidney injury (AKI) is common in patients with multiple myeloma (MM). Whether serum free light chain (sFLC) measurements can distinguish between myeloma and other causes of AKI requires confirmation to guide early treatment. A rapid and portable sFLC test (Seralite®) is newly available and could reduce delays in obtaining sFLC results and accelerate diagnosis in patients with unexplained AKI. This study evaluated the accuracy of Seralite® to identify MM as the cause of AKI. sFLCs were retrospectively analysed in patients with AKI stage 3 as per KDIGO criteria (i.e. serum creatinine ≥354 μmol/L or those on dialysis treatment) (n = 99); 45/99 patients had a confirmed MM diagnosis. The Seralite® κ:λ FLC ratio accurately diagnosed all MM patients in the presence of AKI: a range of 0.14–2.02 returned 100% sensitivity and specificity for identifying all non-myeloma related AKI patients. The sFLC difference (dFLC) also demonstrated high sensitivity (91%) and specificity (100%): an optimal cut-off of 399 mg/L distinguished between myeloma and non-myeloma AKI patients. We propose a pathway of patient screening and stratification in unexplained AKI for use of Seralite® in clinical practice, with a κ:λ ratio range of 0.14–2.02 and dFLC 400 mg/L as decision points. Seralite® accurately differentiates between AKI due to MM and AKI due to other causes in patients considered at risk of myeloma. This rapid test can sensitively screen for MM in patients with AKI and help inform early treatment intervention.Keywords
This publication has 26 references indexed in Scilit:
- Diagnosis and monitoring for light chain only and oligosecretory myeloma using serum free light chain testsBritish Journal of Haematology, 2017
- Measurement of free light chains – pros and cons of current methodsClinical Chemistry and Laboratory Medicine (CCLM), 2016
- The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney diseaseKidney International, 2015
- N Latex FLC serum free light-chain assays in patients with renal impairmentClinical Chemistry and Laboratory Medicine (CCLM), 2014
- Myeloma kidney: advances in molecular mechanisms of acute kidney injury open novel therapeutic opportunitiesNephrology Dialysis Transplantation, 2012
- Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysisNephrology Dialysis Transplantation, 2012
- Renal failure in multiple myeloma: a medical emergencyBone Marrow Transplantation, 2011
- Epidemiology of CKD in Europe: an uncertain scenarioNephrology Dialysis Transplantation, 2010
- Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failureBMC Nephrology, 2008
- Early Mortality After Diagnosis of Multiple Myeloma: Analysis of Patients Entered Onto the United Kingdom Medical Research Council Trials Between 1980 and 2002—Medical Research Council Adult Leukaemia Working PartyJournal of Clinical Oncology, 2005